In this cohort of patients, the existing antihyperglycemic regimens were ineffective at maintaining blood glucose levels within the normal range following the development of ICI-DM, necessitating a change in their diabetes management plans (either by increasing the dosage of subcutaneous insulin injections, or by adding other oral hypoglycemic agents). Here, INS is linked to diabetes mellitus.